Lesinidase alfa

DB15267Investigational

Lesinidase alfa is under investigation in clinical trial NCT02324049 (Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)).

Mechanism: Pharmacologically active on Alpha-N-acetylglucosaminidase
Curator reviewed
Code names: SBC-103

Resolves to

Compound

UNII61A4G0P3IBCAS1522433-40-4

Targets

P54802NAGLU

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Lesinidase alfa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account